Skip to content

Respiratory microbiome and clinical data analysis for the prediction of acute exacerbations in COPD

Respiratory microbiome and clinical data analysis for the prediction of acute exacerbations in COPD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON26474
Enrollment
300
Registered
2021-10-18
Start date
2021-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

None listed

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Age = 18 years • Written informed consent • Physician-confirmed diagnosis of COPD (spirometry) (FEV1= 80% predicted) • Smoking history: Min. 10 packyears

Exclusion criteria

Exclusion criteria: • Inability to understand the nature, scope, and possible consequences of the study • Life expectancy of less than 12 months • Newly diagnosed active pulmonary tuberculosis within the last 12 months • Unstable cardiopulmonary or metabolic co-morbidities • Macrolide maintenance treatment

Design outcomes

Primary

MeasureTime frame
Accuracy of risk assessment for the prediction of acute exacerbations of COPD based on microbiological and clinical analyses.

Secondary

MeasureTime frame
• Composition of the respiratory microbiota in patients with COPD and relation to exacerbation history and clinical parameters • Compositional clustering of respiratory microbiota in relation to disease phenotype • Stability of the respiratory microbiota in patients with COPD in the stable phase, during exacerbation and recovery • Host gene signatures in relation to respiratory microbiota profile

Contacts

Public ContactCarmen Reumkens

Maastricht University

c.reumkens@maastrichtuniversity.nl043 3876644

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)